I C Van Gelder

Summary

Affiliation: University Medical Center Groningen
Country: The Netherlands

Publications

  1. ncbi Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 8:935-42. 2006
  2. ncbi Case of the month by the EHRA Education committee: exercise-related arrhythmias
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 10:235-7, 256. 2008
  3. ncbi Case of polymorphic ventricular tachycardia after stroke necessitating defibrillation
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 10:77-8; 124. 2008
  4. ncbi [Rhythm control as treatment for patients with medication-resistant atrial fibrillation: maze surgery and percutaneous pulmonary vein isolation by catheter ablation]
    I C Van Gelder
    Universitair Medisch Centrum Groningen, afd Cardiologie, Thoraxcentrum
    Ned Tijdschr Geneeskd 150:2294-6. 2006
  5. ncbi [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy]
    I C Van Gelder
    Universitair Medisch Centrum Groningen, Postbus 30 001, 9700, RB Groningen
    Ned Tijdschr Geneeskd 150:2238-44. 2006
  6. ncbi The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm
    Isabelle C Van Gelder
    Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 8:943-9. 2006
  7. ncbi RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II
    Isabelle C Van Gelder
    University Medical Center Groningen, University of Groningen, The Netherlands
    Am Heart J 152:420-6. 2006
  8. ncbi Lenient versus strict rate control in patients with atrial fibrillation
    Isabelle C Van Gelder
    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    N Engl J Med 362:1363-73. 2010
  9. ncbi How to prevent ICD shocks: part I
    Sandra Buck
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands
    Europace 10:1110-1. 2008
  10. ncbi Rationale and current perspective for early rhythm control therapy in atrial fibrillation
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Europace 13:1517-25. 2011

Collaborators

Detail Information

Publications37

  1. ncbi Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 8:935-42. 2006
    ..The AFFIRM and RACE studies showed that rate control is an acceptable treatment strategy for atrial fibrillation (AF). We examined whether strict rate control offers benefit over more lenient rate control...
  2. ncbi Case of the month by the EHRA Education committee: exercise-related arrhythmias
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 10:235-7, 256. 2008
    ..This case describes two nephews with exercise-related arrhythmias...
  3. ncbi Case of polymorphic ventricular tachycardia after stroke necessitating defibrillation
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 10:77-8; 124. 2008
    ..This case describes the occurrence of a tachycardia occurring early after a subarachnoid haemorrhage...
  4. ncbi [Rhythm control as treatment for patients with medication-resistant atrial fibrillation: maze surgery and percutaneous pulmonary vein isolation by catheter ablation]
    I C Van Gelder
    Universitair Medisch Centrum Groningen, afd Cardiologie, Thoraxcentrum
    Ned Tijdschr Geneeskd 150:2294-6. 2006
    ..New techniques have now emerged, including pulmonary vein isolation by means of percutaneous catheter ablation. This is less invasive and therefore nowadays the treatment of first choice if pharmacological rhythm control has failed...
  5. ncbi [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy]
    I C Van Gelder
    Universitair Medisch Centrum Groningen, Postbus 30 001, 9700, RB Groningen
    Ned Tijdschr Geneeskd 150:2238-44. 2006
    ....
  6. ncbi The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm
    Isabelle C Van Gelder
    Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    Europace 8:943-9. 2006
    ..Although early intervention to limit the progression of this arrhythmia is hindered by the limitations of existing anti-arrhythmic therapies, it is nevertheless a critical goal...
  7. ncbi RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II
    Isabelle C Van Gelder
    University Medical Center Groningen, University of Groningen, The Netherlands
    Am Heart J 152:420-6. 2006
    ..Recent studies demonstrated that rate control is an acceptable alternative for rhythm control in patients with persistent atrial fibrillation (AF). However, optimal heart rate during AF is still unknown...
  8. ncbi Lenient versus strict rate control in patients with atrial fibrillation
    Isabelle C Van Gelder
    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    N Engl J Med 362:1363-73. 2010
    ..We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation...
  9. ncbi How to prevent ICD shocks: part I
    Sandra Buck
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands
    Europace 10:1110-1. 2008
  10. ncbi Rationale and current perspective for early rhythm control therapy in atrial fibrillation
    Isabelle C Van Gelder
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Europace 13:1517-25. 2011
    ..In the present paper we describe the background of these studies and provide some information on their design...
  11. ncbi Prognostic significance of atrial arrhythmias in a primary prevention ICD population
    Isabelle C Van Gelder
    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Pacing Clin Electrophysiol 34:1070-9. 2011
    ....
  12. ncbi Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation
    I C Van Gelder
    Department of Cardiology, Thoraxcenter, University Hospital Groningen, The Netherlands
    J Cardiovasc Electrophysiol 10:552-60. 1999
    ..Abnormalities in the calcium handling in response to tachycardia-induced intracellular calcium overload play a pivotal role in these processes...
  13. ncbi Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation
    B J Brundel
    Department of Cardiology, Thoraxcenter University Hospital Groningen, The Netherlands
    Circulation 103:684-90. 2001
    ..We investigated underlying molecular changes by studying the relation between gene expression of the L-type calcium channel and potassium channels and AERP in patients with AF...
  14. ncbi Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial
    Sheba Ahmed
    Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
    JAMA 300:1784-92. 2008
    ..Amiodarone effectively suppresses atrial fibrillation but causes many adverse events...
  15. ncbi Cardiac gene expression profiling - the quest for an atrium-specific biomarker
    A H Maass
    Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, 30 001, 9700, RB Groningen, The Netherlands
    Neth Heart J 18:610-4. 2010
    ..The identified genes need to be confirmed in human tissue and might ultimately be tested as potential biomarkers for atrial stress. (Neth Heart J 2010;18:610-4.)...
  16. ncbi VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation
    T van Noord
    Department of Cardiology, Thoraxcenter, University Hospital Groningen, The Netherlands
    J Cardiovasc Electrophysiol 12:766-9. 2001
    ..Median time to recurrence was 5 days (range 0 to 26) versus 8 days (range 2 to 28) (P = NS), respectively. CONCLUSION: Stand-alone intracellular calcium lowering by verapamil around ECV does not enhance cardioversion outcome...
  17. ncbi [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder]
    M Rienstra
    Universitair Medisch Centrum Groningen, Thoraxcentrum, afd. Cardiologie, RB Groningen
    Ned Tijdschr Geneeskd 150:1027-31. 2006
    ..A low-voltage electrocardiogram is suggestive of left ventricular damage. For these patients, electric cardioversion is a better alternative...
  18. ncbi [Cardiac rehabilitation in patients with a congenital heart disease, an implantable cardioverter defibrillator or chronic heart failure]
    J Brügemann
    Thoraxcentrum, Academisch Ziekenhuis, Postbus 30 001, 9700 RB Groningen
    Ned Tijdschr Geneeskd 148:1809-15. 2004
    ..Patients with stable chronic heart failure should continue their physical training in order to maintain its beneficial physical and psychological effects...
  19. ncbi Endothelin system in human persistent and paroxysmal atrial fibrillation
    B J Brundel
    Department of Cardiology, Thoraxcenter University Hospital Groningen, The Netherlands
    J Cardiovasc Electrophysiol 12:737-42. 2001
    ..The purpose of this study was to investigate mRNA and protein expression levels of the endothelin system in AF patients with and without concomitant underlying valve disease...
  20. ncbi Radiofrequency ablation of atrial fibrillation
    A C P Wiesfeld
    Thoraxcenter, University Hospital Groningen, Department of Cardiology P O Box 30 001, 9700 RB Groningen, The Netherlands
    Int J Cardiol 93:231-7. 2004
    ..However, it is only successful in one third of the patients. Further investigations are warranted to identify the ideal patient, as well as to develop better ablation strategies...
  21. ncbi Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy
    B A Schoonderwoerd
    Department of Cardiology, University Hospital Groningen, The Netherlands
    J Cardiovasc Electrophysiol 12:1404-10. 2001
    ..Our aim was to establish the influence of concomitant high ventricular rate and consequent development of CHF on electrical remodeling and dilation during atrial tachycardia...
  22. ncbi Pulmonary vein isolation of symptomatic refractory paroxysmal and persistent atrial fibrillation: A single centre and single operator experience in the Netherlands
    E S Tan
    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Neth Heart J 17:366-72. 2009
    ..Conclusion. Independent determinants of a successful outcome after PVI are paroxysmal AF and a longer left atrial ablation time. (Neth Heart J 2009;17:366-72.)...
  23. ncbi [Cardiological (pharmaco)therapy and dental practice]
    J Brügemann
    Cardiologie, Universitair Medisch Centrum Groningen
    Ned Tijdschr Tandheelkd 113:75-81. 2006
    ..In case of urgent and/or extended dental procedures, admittence to a hospital must be considered to secure optimal therapy...
  24. ncbi Cardiac gene expression profiling - the quest for an atrium-specific biomarker
    A H Maass
    Departments of Cardiology and Experimental Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Neth Heart J 18:610-4. 2010
    ..The identified genes need to be confirmed in human tissue and might ultimately be tested as potential biomarkers for atrial stress. (Neth Heart J 2010;18:610-4.)...
  25. ncbi Current treatment recommendations in antiarrhythmic therapy
    I C Van Gelder
    Department of Cardiology, Thoraxcenter, University Hospital Groningen, The Netherlands
    Drugs 55:331-46. 1998
    ..This may imply that an increasing number of patients will be candidates for such a device. However, it will be necessary to await publication of data involving these devices from current ongoing studies...
  26. ncbi Paroxysmal atrial fibrillation, quality of life and neuroticism
    M P van den Berg
    Department of Cardiology, Thorax Centre, Groningen University Medical Centre, Groningen, The Netherlands
    Neth J Med 63:170-4. 2005
    ..We sought to investigate the potential role of neuroticism in the impairment of QoL in patients with paroxysmal AF...
  27. ncbi Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
    J H H Deuling
    Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Neth Heart J 20:148-54. 2012
    ....
  28. ncbi Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report
    R V H P Huijskes
    Department of Cardiology, Medical Center Leeuwarden, The Netherlands
    Neth Heart J 17:438-41. 2009
    ..Neth Heart J 2009;17:438-41.)...
  29. ncbi Evaluation of global left ventricular function assessment of non-fluorescent electromechanical endocardial mapping compared with biplane left ventricular contrast angiography
    E S Tan
    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Neth Heart J 18:72-7. 2010
    ..Neth Heart J 2010;18:72-77.)...
  30. ncbi Cardiac resynchronisation therapy and the role of optimal device utilisation
    S Buck
    Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Neth Heart J 17:354-7. 2009
    ..By optimising programming of the device response to cardiac resynchronisation, therapy can be improved. (Neth Heart J 2009;17:354-7.)...
  31. ncbi Predictors of ventricular tachyarrhythmia in high-risk myocardial infarction patients treated with primary coronary intervention
    J R Timmer
    Department of Cardiology, Thorax Center, University Medical Center Groningen, Groningen currently Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
    Neth Heart J 18:122-8. 2010
    ..Independent predictors of VT are younger age, TIMI 0-1 flow prior to PCI and larger infarct size. The presence of early VT was not significantly associated with one-year mortality. (Neth Heart J 2010;18:122-8.)...
  32. ncbi Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels
    B J Brundel
    Department of Cardiology, Thoraxcenter University Hospital Groningen, The Netherlands
    J Am Coll Cardiol 37:926-32. 2001
    ..Our purpose was to determine whether patients with persistent atrial fibrillation (AF) and patients with paroxysmal AF show alterations in potassium channel expression...
  33. ncbi Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
    A C P Wiesfeld
    Int J Cardiol 107:140-1. 2006
  34. ncbi Treatment of atrial fibrillation
    Y Blaauw
    Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands
    Heart 88:432-7. 2002
  35. ncbi Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study
    Jean Marc Davy
    Cardiology Department, University Hospital, CHU Montpellier, Montpellier, France
    Am Heart J 156:527.e1-9. 2008
    ....
  36. ncbi Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome
    M B Rook
    Department of Medical Physiology, Utrecht University, The Netherlands
    Cardiovasc Res 44:507-17. 1999
    ..This syndrome is associated with a high mortality rate and has been shown to display familial occurrence...
  37. ncbi [Arrhythmogenic right-ventricular cardiomyopathy: different manifestations as precursors of sudden death which might be prevented]
    P van der Harst
    Academisch Ziekenhuis, Postbus 30.001, 9700 RB, Groningen
    Ned Tijdschr Geneeskd 148:2396-402. 2004
    ..Furthermore, since genetics play an important role and ARVC can be asymptomatic, evaluation of close relatives for preclinical symptoms is important...